|
Women's Health Study: Continued Follow-up
|
5R01CA047988-21
|
$1,813,397
|
$362,679
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Washington University Molecular Imaging Center
|
2P50CA094056-12
|
$1,428,925
|
$185,760
|
PIWNICA-WORMS, DAVID
|
WASHINGTON UNIVERSITY
|
|
VITamin D and omegA-3 triaL (VITAL)
|
3U01CA138962-04S1
|
$167,479
|
$33,496
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-04
|
$1,548,411
|
$309,682
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Vasculogenesis in Ewing's Sarcoma: Implications for Therapy
|
5R01CA103986-08
|
$246,403
|
$246,403
|
Kleinerman, Eugenie
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Vascular Biology in Cancer
|
ZIABC011390
|
$1,292,548
|
$323,137
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
Using mouse knockouts to unravel endothelial gene function
|
ZIABC010736
|
$223,398
|
$22,340
|
St. Croix, Brad
|
CCR (NCI)
|
|
Using Diazeniumdiolate Chemistry to Design Nitric Oxide-Based Therapies
|
ZIABC005673
|
$641,141
|
$128,228
|
Keefer, Larry
|
CCR (NCI)
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
2P30CA046592-24
|
$5,694,947
|
$56,949
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S1
|
$49,948
|
$499
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-24S2
|
$74,872
|
$749
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
TEM5 Ligand Hunt
|
ZIABC010483
|
$335,097
|
$67,019
|
St. Croix, Brad
|
CCR (NCI)
|
|
Spatial and Temporal Regulation of Angiogenesis
|
5P01CA092644-09
|
$1,606,297
|
$481,889
|
DVORAK, HAROLD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
|
ZIABC010300
|
$570,011
|
$57,001
|
McVicar, Daniel
|
CCR (NCI)
|
|
Search for New Tumor Endothelial Markers
|
ZIABC010486
|
$111,699
|
$33,510
|
St. Croix, Brad
|
CCR (NCI)
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S1
|
$107,301
|
$1,073
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S2
|
$140,000
|
$1,400
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-36S3
|
$75,000
|
$750
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
5P30CA016056-36
|
$3,960,459
|
$39,605
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roles of Glycoconjugates and Redox Signaling in Tumor Biology
|
ZIASC009174
|
$298,239
|
$29,824
|
Roberts, David
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIABC010391
|
$539,792
|
$107,958
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Regulation of Vascular Stabilization by Connexin 43
|
5R01CA138727-04
|
$297,887
|
$297,887
|
METHENY-BARLOW, LINDA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Redox Mechanism Process of Angiogenesis and Wound Healing
|
ZIABC010898
|
$275,945
|
$27,595
|
Wink, David
|
CCR (NCI)
|
|
Quantitative ultrasound analysis of vascular morphology for cancer assessment
|
1R43CA165621-01
|
$151,294
|
$60,518
|
AYLWARD, STEPHEN
|
KITWARE, INC.
|
|
Physiological Factors in Hyperthermia
|
3R01CA044114-22S1
|
$47,652
|
$28,591
|
Griffin, Robert
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Physiological Factors in Hyperthermia
|
5R01CA044114-22
|
$291,849
|
$175,109
|
Griffin, Robert
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
Photodynamic therapy for neoplastic diseases involving serosal surfaces
|
5P01CA087971-10
|
$1,552,554
|
$388,139
|
GLATSTEIN, ELI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIABC010789
|
$463,931
|
$46,393
|
Thiele, Carol
|
CCR (NCI)
|
|
Nitric Oxide in Tumor Angiogenesis, Microcirculation and Radiation Therapy
|
5R01CA096915-10
|
$302,174
|
$302,174
|
FUKUMURA, DAI
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
|
ZICBC010953
|
$873,253
|
$87,325
|
Simpson, Robert
|
CCR (NCI)
|
|
Molecular Mechanisms of the Hypoxic Response
|
5R01CA153347-08
|
$259,515
|
$259,515
|
LEE, FRANK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIABC005270
|
$1,371,351
|
$68,568
|
Blumberg, Peter
|
CCR (NCI)
|
|
Micro-tumor detection by quantifying tumor-induced vascular abnormalities (PQ-13)
|
1R01CA170665-01
|
$456,910
|
$228,455
|
Dayton, Paul
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Metalloproteinases in tumor neovascularization
|
5R01CA083017-14
|
$320,603
|
$320,603
|
Strongin, Alex
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
Matrix Metalloproteinase-Dependent Angiogenesis
|
5R01CA088308-12
|
$313,314
|
$313,314
|
WEISS, STEPHEN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Leukocyte-Endothelial Adhesion in Tumor Immunity
|
5R01CA079765-12
|
$314,958
|
$157,479
|
Evans, Sharon
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
In situ anti-tumor immunity and effects of radiation
|
5R01CA028332-32
|
$243,832
|
$243,832
|
Lord, Edith
|
UNIVERSITY OF ROCHESTER
|
|
High Contrast Ultrasound Imaging
|
5R21CA149543-02
|
$201,496
|
$100,748
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Functional Analysis of TEM5 and TEM8
|
ZIABC010484
|
$223,398
|
$111,699
|
St. Croix, Brad
|
CCR (NCI)
|
|
Flow-based remodeling and function of tumor vasculature
|
5R01CA149285-03
|
$320,632
|
$320,632
|
MUNN, LANCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
FASEB SRC on AMP-activated protein kinase
|
1R13CA176821-01
|
$6,000
|
$6,000
|
YOUNG, LAWRENCE
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
|
Epidemiology of Cancer in a Cohort of Older Women
|
5R01CA039742-28
|
$442,527
|
$88,505
|
LAZOVICH, DEANN
|
UNIVERSITY OF MINNESOTA
|
|
Downstream of Akt in the tumor vessel
|
5R01CA131152-05
|
$452,831
|
$452,831
|
Aird, William
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Development of a preclinical optical frequency domain angiography instrument
|
1R01CA163528-01
|
$464,845
|
$464,845
|
Vakoc, Benjamin
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Determining the clinical significance of monoclonal gammopathy of undetermined si
|
5R03CA152374-02
|
$59,163
|
$19,524
|
Go, Ronald
|
GUNDERSEN LUTHERAN MEDICAL FOUNDATION
|
|
Determinants of late cardiovascular morbidity among survivors of hematopoietic ce
|
5K07CA151775-02
|
$151,059
|
$75,530
|
Chow, Eric
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Comprehensive Cancer Center of Wake Forest University
|
2P30CA012197-37
|
$1,318,600
|
$52,744
|
GARVIN, ABBOTT
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Comprehensive Cancer Center of Wake Forest University
|
3P30CA012197-37S1
|
$74,844
|
$2,994
|
GARVIN, ABBOTT
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Comprehensive Cancer Center of Wake Forest COOP Research Base
|
2U10CA081851-12
|
$2,186,242
|
$87,450
|
SHAW, EDWARD
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Comparative Biomedical Scientist Training Program
|
ZIGBC010931
|
$632,356
|
$31,618
|
Simpson, Robert
|
CCR (NCI)
|
Total relevant funding to Vascular Disease for this search: $8,696,035
|